Disease/vaccine
|
Foals/weanlings
|
Yearlings
|
Performance Horses
|
Pleasure Horses
|
Broodmares
|
Comments
|
Tetanus toxoid
|
From nonvaccinated
mare: First dose: 3 to 4 months Second
dose: 4 to 5 months From vaccinated mare :
First dose: 6 months Second dose: 7 months Third dose: 8 to 9 months
|
Annual
|
Annual
|
Annual
|
Annual, 4 to 6 weeks prepartum
|
Booster at time of penetrating
injury or surgery if last dose not administered within 6 months
|
Disease/vaccine
|
Foals/weanlings
|
Yearlings
|
Performance Horses
|
Pleasure Horses
|
Broodmares
|
Comments
|
Encephalomyelitis
(EEE, WEE, VEE)
|
EEE: (in high-risk
areas) First dose: 3 to 4 months Second
dose: 4 to 5 months Third dose: 5 to 6 months
WEE, EEE (in low-risk areas) and VEE:
From nonvaccinated mare: First dose: 3 to 4 months Second dose: 4 to 5
months Third dose: 5 to 6 months From vaccinated mare: First dose: 6
months Second dose: 7 months Third dose: 8 months
|
Annual, spring
Annual, spring
|
Annual, spring
Annual, spring
|
Annual, spring
Annual, spring
|
Annual, 4 to 6 weeks prepartum
Annual, 4 to 6 weeks prepartum
|
In endemic areas booster EEE and WEE
every 6 months; VEE only needed when threat of exposure; VEE may only be
available as a combination vaccine with EEE and WEE.
|
Disease/vaccine
|
Foals/weanlings
|
Yearlings
|
Performance Horses
|
Pleasure Horses
|
Broodmares
|
Comments
|
Rabies
|
Foals born to non-vaccinated mares:
First dose: 3 to 4 months
Foals born to vaccinated mares: First dose: 6 months
|
Annual
|
Annual
|
Annual
|
Annual, can be done before breeding
and should be boostered 4 to 6 weeks prepartum.
|
Vaccination recommended in endemic
areas. Do not use modified-live-virus vaccines in horses.
|
Disease/vaccine
|
Foals/weanlings
|
Yearlings
|
Performance Horses
|
Pleasure Horses
|
Broodmares
|
Comments
|
Influenza
|
Inactivated injectable:
From nonvaccinated mare: First dose: 6 months Second dose: 7 months
Third dose: 8 months Then at 3-month intervals From vaccinated mare:
First dose: 9 months Second dose: 10 months Third dose: 11 to 12 months
Then at 3-month intervals Intranasal modified live virus :
First dose: 11 months; has been safely administered to foals less than
11 months - see comments
|
Every 3 to 4 monthsEvery 6 months
|
Every 3 to 4 monthsEvery 6 months
|
Annual with added boosters prior to
likely exposure
Every 6 months
|
At least semiannual, with 1 booster
4 to 6 weeks prepartum,
Annual before breeding (see comments)
|
A series of at least 3 doses is
recommended for primary immunization of foals. Not recommended for
pregnant mares until data available. Use inactivated vaccine for
prepartum booster. If first dose is administered to foals less than 11
months of age, administer 2nd dose at or after 11 months of age.
|
Disease/vaccine
|
Foals/weanlings
|
Yearlings
|
Performance Horses
|
Pleasure Horses
|
Broodmares
|
Comments
|
Rhinopneumonitis
(EHV-1 and EHV-4)
|
First dose: 4 to 6 months
Second dose: 5 to 7 months
Third dose: 6 to 8 months
Recommend modified live virus vaccine.
|
Booster every 3 to 4 months up to
annually. Recommend modified live virus vaccine.
|
Optional: use modified live virus
vaccine.
|
Optional: Not recommended at this
time.
|
Fifth, seventh, ninth month of gestation (inactivated EHV-1 vaccine);
optional dose at third month of gestation if high exposure risk.
|
Vaccination of mares before breeding
and 4 to 6 weeks prepartum is suggested. Breeding stallions should be
vaccinated before the breeding season.
|
Disease/vaccine
|
Foals/weanlings
|
Yearlings
|
Performance Horses
|
Pleasure Horses
|
Broodmares
|
Comments
|
West Nile Virus
|
Intervet product -
(Prevenile)
Single dose at 5 months of age. No booster needed.
|
Annual booster, prior to expected
risk. Vaccinate semi-annually,
depending on risk.
|
Annual booster, prior to
expected risk. Vaccinate semi-annually, depending on risk.
|
Annual booster, prior to expected
risk. Vaccinate semi-annually, depending on risk.
|
Annual, 4 to 6 weeks prepartum.
|
Annual booster In endemic areas, booster as required or warranted due to local
conditions conducive to disease risk. Vaccinate semi-annually, depending on risk
and vaccine type.
|
Disease/vaccine
|
Foals/weanlings
|
Yearlings
|
Performance Horses
|
Pleasure Horses
|
Broodmares
|
Comments
|
Strangles
|
Injectable: First
dose: 4 to 6 months Second dose: 5 to 7 months Third dose: 7 to 8 months
(depending on the product used) Fourth dose: 12 months
Intranasal: First dose: 6 to 9 months.
|
Optional: Semi-annual if risk is
high.
|
Optional: semi-annual if risk is
high.
|
Optional: semi-annual if risk is
high.
|
Intranasal product can be used in
pregnant mares. In high risk situations, 1 dose of
inactivated M-protein vaccine 4 to 6 weeks prepartum
|
Vaccines containing M-protein
extract may be less reactive than whole-cell vaccines. Use when endemic
conditions exist or risk is high. Foals as young as 6 weeks-of-age may
safely receive the intranasal product. A second dose should be
administered 2 to 4 weeks prior to weaning.
|
Disease/vaccine
|
Foals/weanlings
|
Yearlings
|
Performance Horses
|
Pleasure Horses
|
Broodmares
|
Comments
|
Potomac Horse Fever
|
First dose: 5 to 6 months Second
dose: 6 to 7 months in endemic areas.
|
Optional
|
Optional
|
Optional
|
Optional: 1 dose 4 to 6 weeks prepartum
|
Booster during May to June in
endemic areas.
|